Total Payments
$17,622
2024 Payments
$2,833
Companies
35
Transactions
573
Medicare Patients
3,057
Medicare Billing
$347,473
Payment Breakdown by Category
Food & Beverage$17,564 (99.7%)
Education$57.75 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,564 | 566 | 99.7% |
| Education | $57.75 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,703 | 74 | $0 (2024) |
| Amgen Inc. | $2,611 | 51 | $0 (2024) |
| Lilly USA, LLC | $1,676 | 85 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,616 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,486 | 60 | $0 (2024) |
| Gilead Sciences, Inc. | $1,004 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $860.03 | 30 | $0 (2022) |
| Novo Nordisk Inc | $835.48 | 46 | $0 (2024) |
| Allergan Inc. | $590.52 | 11 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $549.96 | 22 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,833 | 56 | Gilead Sciences, Inc. ($420.42) |
| 2023 | $1,972 | 54 | Amgen Inc. ($336.02) |
| 2022 | $1,530 | 47 | ABBVIE INC. ($263.89) |
| 2021 | $1,635 | 56 | AbbVie Inc. ($310.85) |
| 2020 | $1,429 | 50 | Amgen Inc. ($351.81) |
| 2019 | $2,724 | 81 | Amgen Inc. ($605.88) |
| 2018 | $2,679 | 111 | AbbVie, Inc. ($541.65) |
| 2017 | $2,820 | 118 | AbbVie, Inc. ($520.85) |
All Payment Transactions
573 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.91 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $121.63 | General |
| Category: HCV | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $123.41 | General |
| 10/25/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: HBV | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 09/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: DIABETES | ||||||
| 08/08/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Endocrinology | ||||||
| 07/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Bone Health | ||||||
| 07/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/23/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $151.24 | General |
| Category: Immunology | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: DIABETES | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 636 | 1,503 | $151,400 | $83,911 |
| 2022 | 10 | 683 | 1,605 | $154,235 | $88,101 |
| 2021 | 10 | 836 | 1,650 | $166,510 | $98,875 |
| 2020 | 8 | 902 | 1,669 | $160,855 | $76,587 |
Total Patients
3,057
Total Services
6,427
Medicare Billing
$347,473
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 496 | $79,360 | $51,088 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 295 | $41,205 | $21,465 | 52.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,600 | $1,767 | 67.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $2,800 | $1,759 | 62.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 136 | 485 | $7,275 | $1,557 | 21.4% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 13 | 50 | $7,500 | $1,379 | 18.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 14 | $2,300 | $1,360 | 59.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 18 | $2,540 | $1,339 | 52.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $990.00 | $970.20 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 58 | $3,480 | $675.45 | 19.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 27 | 27 | $1,350 | $552.42 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 481 | $76,960 | $49,797 | 64.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 188 | 383 | $53,525 | $28,295 | 52.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 19 | $3,040 | $2,038 | 67.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 153 | 556 | $8,340 | $1,801 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $2,200 | $1,546 | 70.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 22 | $3,120 | $1,517 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 29 | 29 | $870.00 | $852.60 | 98.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 28 | 28 | $840.00 | $823.20 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 39 | 63 | $3,780 | $753.81 | 19.9% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 11 | 13 | $1,560 | $677.07 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 210 | 488 | $78,080 | $52,165 | 66.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 175 | 287 | $40,125 | $21,810 | 54.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 91 | 106 | $16,940 | $11,082 | 65.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 71 | 84 | $11,780 | $6,216 | 52.8% |
About Dr. Nicholas Tran, M.D
Dr. Nicholas Tran, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Westminster, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265498349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Tran, M.D has received a total of $17,622 in payments from pharmaceutical and medical device companies, with $2,833 received in 2024. These payments were reported across 573 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($17,564).
As a Medicare-enrolled provider, Tran has provided services to 3,057 Medicare beneficiaries, totaling 6,427 services with total Medicare billing of $347,473. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Westminster, CA
- Active Since 04/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1265498349
Products in Payments
- JARDIANCE (Drug) $1,663
- FARXIGA (Drug) $1,237
- EVENITY (Biological) $1,092
- Vemlidy (Drug) $882.28
- Prolia (Biological) $783.89
- Repatha (Biological) $701.85
- CREON (Drug) $636.95
- TRULICITY (Drug) $582.58
- LINZESS (Drug) $528.23
- INVOKANA (Drug) $510.41
- Ozempic (Drug) $486.30
- TRADJENTA (Drug) $452.71
- Synthroid (Drug) $395.62
- SYNTHROID (Drug) $387.55
- TOUJEO (Drug) $375.15
- Tymlos (Biological) $344.54
- BAQSIMI (Drug) $304.61
- JANUVIA (Drug) $303.06
- SOLIQUA (Drug) $297.79
- VIBERZI (Drug) $293.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Westminster
Sara Loeffler, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $108,314
Endocrinology, Diabetes & Metabolism $108,314
Lan Nguyen, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $3,828
Endocrinology, Diabetes & Metabolism $3,828
Dr. Mahfuzul Khan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $762.16
Endocrinology, Diabetes & Metabolism $762.16
Sunil Gurung, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $623.47
Endocrinology, Diabetes & Metabolism $623.47